Emerging therapeutic targets in antiviral and anticancer therapy: a role for ribonucleotide reductase

Author： Novotny L.   Fritzer-Szekeres M.   Szekeres T.  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.3, Iss.2, 1999-06, pp. : 251-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting ribonucleotide reductase for cancer therapy

By Shao Jimin   Liu Xiyong   Zhu Lijun   Yen Yun  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 12, 2013-12 ,pp. : 1423-1437

Informa Healthcare

Access to resources Recommend Favorite

Emerging therapeutic targets in asthma: a role for interleukin-9

By Levitt R.C.   Nicolaides N.C.  

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 1, 1999-03 ,pp. : 41-51

Informa Healthcare

Access to resources Recommend Favorite

Ribonucleotide reductase: target therapy for human disease

By Gallicchio Vincent S  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 6, 2005-06 ,pp. : 659-673

Informa Healthcare

Access to resources Recommend Favorite

Helicases as Antiviral and Anticancer Drug Targets

By  

Current Medicinal Chemistry, Vol. 14, Iss. 8, 2007-04 ,pp. : 883-915

Bentham Science Publishers

Access to resources Recommend Favorite

Matrix metalloproteinases as emerging targets in anticancer therapy: status and prospects

By Sternlicht M.D.   Bergers G.  

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 5, 2000-10 ,pp. : 609-633

Informa Healthcare

Access to resources Recommend Favorite